Janssen is now under the new Johnson & Johnson brand in Greece, with the change in its corporate identity representing the company’s long-term commitment to innovation and advancing health worldwide.
Specifically, Janssen Greece, the pharmaceutical division of Johnson & Johnson, has also been renamed as Johnson & Johnson Innovative Medicine in Greece. The new corporate identity includes a renewed logo, colors and font that have already been introduced to the Greek company and will gradually be integrated into all the company’s product materials and packaging.
On the occasion of the new identity, Christian Rodseth, CEO of Johnson & Johnson Innovative Medicine for Greece, Poland and Romania, highlighted that this is not just a change, but reflects the group’s long-term commitment to innovative medicine and providing treatments that aim to improve patients’ lives.
It should be noted that Johnson & Johnson has been providing health products and solutions to people around the world for more than 135 years. Last fall, it announced a global strategy to integrate Johnson & Johnson MedTech – the medical technology business – and Johnson & Johnson Innovative Medicine – the pharmaceutical business – under the Johnson & Johnson brand.